Onconova Therapeutics, Inc. (ONTX): Price and Financial Metrics

ONTX POWR Grades

• Sentiment is the dimension where ONTX ranks best; there it ranks ahead of 98.75% of US stocks.
• ONTX's strongest trending metric is Sentiment; it's been moving up over the last 179 days.
• ONTX's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

ONTX Stock Summary

• For ONTX, its debt to operating expenses ratio is greater than that reported by merely 0.5% of US equities we're observing.
• ONTX's price/sales ratio is 179.37; that's higher than the P/S ratio of 98.53% of US stocks.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ONTX comes in at -137.06% -- higher than that of only 2.58% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Onconova Therapeutics Inc are NAVB, AEIS, MYSZ, GEOS, and SCYX.
• ONTX's SEC filings can be seen here. And to visit Onconova Therapeutics Inc's official web site, go to www.onconova.com.

ONTX Valuation Summary

• ONTX's price/earnings ratio is -3.9; this is 110.68% lower than that of the median Healthcare stock.
• Over the past 99 months, ONTX's price/sales ratio has gone up 347.8.
• Over the past 99 months, ONTX's price/sales ratio has gone up 347.8.

Below are key valuation metrics over time for ONTX.

ONTX Growth Metrics

Its 2 year cash and equivalents growth rate is now at 327.26%.
• Its 3 year net income to common stockholders growth rate is now at -22.29%.
• Its year over year price growth rate is now at 70.98%.

Over the past 67 months, ONTX's revenue has gone down $12,589,000.

The table below shows ONTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	0.227	-20.69	-18.828
2021-06-30	0.236	-22.186	-21.616
2021-03-31	0.235	-23.26	-24.78
2020-12-31	0.231	-23.075	-25.157
2020-09-30	0.204	-22.967	-24.475
2020-06-30	0.201	-21.165	-22.829

ONTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ONTX has a Quality Grade of D, ranking ahead of 8.68% of graded US stocks.
• ONTX's asset turnover comes in at 0.007 -- ranking 403rd of 682 Pharmaceutical Products stocks.
• IDRA, MYMD, and CAPR are the stocks whose asset turnover ratios are most correlated with ONTX.

The table below shows ONTX's key quality metrics over time.